Translational Therapeutics
|
Open Access
Featured
-
-
Clinical Study
| Open AccessFOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
- F Bertolini
- , N Malavasi
- & P F Conte
-
Molecular Diagnostics
| Open AccessKRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
- N Knijn
- , L J M Mekenkamp
- & I D Nagtegaal
-
Genetics and Genomics
| Open AccessActivated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin
- S Rachagani
- , S Senapati
- & S K Batra
-
Molecular Diagnostics
| Open AccessFarnesoid X receptor, overexpressed in pancreatic cancer with lymph node metastasis promotes cell migration and invasion
- J Y Lee
- , K T Lee
- & J C Rhee
-
Molecular Diagnostics
| Open AccessExpression of osteopontin coregulators in primary colorectal cancer and associated liver metastases
- D J Mole
- , C O'Neill
- & F C Campbell
-
Molecular Diagnostics
| Open AccessAbrogated expression of DEC1 during oesophageal squamous cell carcinoma progression is age- and family history-related and significantly associated with lymph node metastasis
- V C L Wong
- , J M Y Ko
- & M L Lung
-
Clinical Study
| Open AccessDocetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
- R Petrioli
- , A Pascucci
- & G Francini
-
Translational Therapeutics
| Open AccessTargeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
- B H Kang
- , M Tavecchio
- & D C Altieri
-
Molecular Diagnostics
| Open AccessEnhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
- A Shiirevnyamba
- , T Takahashi
- & H Uehara
-
Molecular Diagnostics
| Open AccessCXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells
- S Amatschek
- , R Lucas
- & C Wiesner
-
Letter to the Editor
| Open AccessComplexity in the regulation of Dicer expression: Dicer variant proteins are differentially expressed in epithelial and mesenchymal breast cancer cells and decreased during EMT
- G W Hinkal
- , G Grelier
- & C Moyret-Lalle
-
Short Communication
| Open AccessPrevention of tumour cell dissemination in diagnostic needle procedures
- H Wiksell
- , K-U Schässburger
- & G Auer
-
Clinical Study
| Open AccessCetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
- C Garufi
- , A Torsello
- & F Cognetti
-
Translational Therapeutics
| Open AccessElevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice
- T Matsuoka
- , J E Adair
- & J D Roberts
-
Molecular Diagnostics
| Open AccessOsteopontin is a marker for cancer aggressiveness and patient survival
- G F Weber
- , G S Lett
- & N C Haubein
-
Clinical Study
| Open AccessUbiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
- D-W Yan
- , D-W Li
- & Z-H Peng
-
Molecular Diagnostics
| Open AccessCo-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
- J Hao
- , H Chen
- & Y Li
-
Molecular Diagnostics
| Open AccessInactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases
- Y Teng
- , M Q Ren
- & J K Cowell
-
Letter to the Editor
| Open AccessAssessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria
- V Vassiliou
- & D Andreopoulos
-
Molecular Diagnostics
| Open AccessANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines
- C Ayoub
- , C Wasylyk
- & B Wasylyk
-
Molecular Diagnostics
| Open AccessCeramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
- P Dziȩgiel
- , T Owczarek
- & M Ugorski
-
Clinical Study
| Open AccessMulti-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases
- M Cosimelli
- , R Golfieri
- & F Izzo
-
Clinical Study
| Open AccessClinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
- L J M Mekenkamp
- , M Koopman
- & C J A Punt
-
Molecular Diagnostics
| Open AccessCharacterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
- T Wang
- , H S Hu
- & S Q Cheng
-
-
Molecular Diagnostics
| Open AccessPresence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
- H Wong
- , S Lau
- & R J Epstein
-
Translational Therapeutics
| Open AccessFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration
- G Sonvilla
- , S Allerstorfer
- & B Marian
-
Clinical Study
| Open AccessTumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer
- T Hamaoka
- , C M Costelloe
- & N T Ueno
-
Molecular Diagnostics
| Open AccessCirculating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
- K Ameri
- , R Luong
- & S S Jeffrey